at-the-market

HCW Biologics Announces Pricing of $1.5 Million Follow-On OfferingPriced At-The-Market Under NASDAQ Rules

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company…

1 week ago

Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

January 02, 2026 17:00 ET  | Source: Intelligent Bio Solutions, Inc. NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent…

2 months ago

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…

3 months ago

Digi Power X Files Amended and Restated Prospectus Supplement for its Existing At-the-Market Equity Program

This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated…

3 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

October 10, 2025 17:16 ET  | Source: Bluejay Diagnostics, Inc. ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…

5 months ago